Align Technology, Inc. (NASDAQ:ALGN) VP Christopher C. Puco sold 8,764 shares of the business’s stock in a transaction that occurred on Friday, November 30th. The shares were sold at an average price of $227.42, for a total transaction of $1,993,108.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
ALGN stock opened at $235.70 on Tuesday. Align Technology, Inc. has a one year low of $188.57 and a one year high of $398.88. The company has a market capitalization of $18.39 billion, a price-to-earnings ratio of 60.59, a P/E/G ratio of 2.00 and a beta of 2.05.
Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, October 24th. The medical equipment provider reported $1.24 EPS for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.05. Align Technology had a net margin of 16.89% and a return on equity of 34.09%. The business had revenue of $505.30 million during the quarter, compared to analysts’ expectations of $503.14 million. During the same quarter in the previous year, the company earned $1.01 EPS. The business’s quarterly revenue was up 31.1% compared to the same quarter last year. As a group, sell-side analysts expect that Align Technology, Inc. will post 4.87 earnings per share for the current year.
Several equities analysts recently commented on ALGN shares. Goldman Sachs Group started coverage on shares of Align Technology in a research note on Saturday, October 20th. They set a “buy” rating and a $420.00 price objective for the company. Stifel Nicolaus reduced their price objective on shares of Align Technology from $425.00 to $346.00 and set a “buy” rating for the company in a research note on Thursday, October 25th. BidaskClub cut shares of Align Technology from a “strong-buy” rating to a “buy” rating in a research note on Friday, October 5th. ValuEngine cut shares of Align Technology from a “strong-buy” rating to a “buy” rating in a research note on Friday, October 26th. Finally, Morgan Stanley reduced their price objective on shares of Align Technology from $320.00 to $300.00 and set an “equal weight” rating for the company in a research note on Thursday, October 25th. Two analysts have rated the stock with a sell rating, three have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $352.20.
TRADEMARK VIOLATION WARNING: “Align Technology, Inc. (ALGN) VP Sells $1,993,108.88 in Stock” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.com-unik.info/2018/12/04/align-technology-inc-algn-vp-sells-1993108-88-in-stock.html.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.